FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.
Position in DYN — Dyne Therapeutics, Inc.
CIK 1280487
TURIN, L6
Position in DYN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,933,802
+$1,929,890 QoQ
Shares Held
87,069
+43434.5% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#98
of 245 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. holds $85,297,931 across 21 Biotechnology names. DYN ranks #13 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
38,752 | $19,249,280 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
35,077 | $10,559,229 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,049 | $10,007,193 | |
| 4 | RPRX |
Royalty Pharma plc
|
140,143 | $7,857,818 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
138,336 | $5,155,782 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
91,018 | $5,005,990 | |
| 7 | INCY |
Incyte Corp
|
42,853 | $4,857,816 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
53,795 | $4,265,405 |
All Filings in DYN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,933,802 | 87,069 | Shares | Defined | 2026-07-23 | |
| 2025-12-31 | $3,912 | 200 | Shares | Defined | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||